The present invention relates to a breast cancer resistance protein (BCRP/ABCG2) inhibitor. The invention provides an acrylonitrile derivative represented by formula (1):
(wherein A represents an optionally substituted 3- to 8-membered heterocyclic ring) or a salt thereof.
